NCT05554367 2026-03-18Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment TrialNational Cancer Institute (NCI)Phase 2 Active not recruiting199 enrolled
NCT04439344 2025-11-19Testing Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol Z1A)National Cancer Institute (NCI)Phase 2 Active not recruiting53 enrolled 10 charts